MILDROCARD-N

Solution for injection 100 mg/ml 5 ml in ampoules No.10

1 ml of the solution contains 100 mg of 3-(2,2,2- trimethylhydrazinium) propionate dihydrate

Antihypoxic and cytoprotective product which increases cell load tolerance

Marketing Authorization No. UA/10376/01/01

MAGNESIUM SULFATE 

Solution for injections of 250 mg/ml of 5 ml in ampoules No.10

Blood substitutes and infusion solutions.

Electrolyte solution.

Marketing Authorization No. UA/20276/01/01

HAEMAXAM

Solution for injection 50 mg/ml5 ml in ampoules No.10

1 ml of the solution contains 50 mg of tranexamic acid

Starting therapy product used during the hemorrhages of different localization

Marketing Authorization No. UA/13418/01/01

WATER FOR INJECTIONS

Solvent for parenteral use of 2 ml and 5 ml No. 10

Solvents and diluents.

Marketing Authorization No. UA/20206/01/01

SODIUM CHLORIDE

Solution for injections of 2 ml and 5 ml No. 10

1 ml of solution contains sodium chloride 9 mg

Blood substitutes and perfusion solutions.

Electrolyte solutions.

Marketing Authorization No. UA/20236/01/01

LIDOCAINЕ

Solution for injection 2 ml No. 10

1 ml of solution contains lidocaine hydrochloride – 20 mg

Local anesthetic drugs. Lidocaine.

Lidocaine is an amide-type local anesthetic with a rapid onset of

action and an intermediate duration of action.

Marketing Authorization No. UA/20258/01/01

EUPHYLLINE

Solution for injection 5 ml No. 10

1 ml of solution contains theophylline 20 mg;

Means for systemic use in obstructive diseases

of the respiratory tract. Xanthines. Theophylline.

Marketing Authorization No. UA/20254/01/01

NIKOMEX 5 ml No.5

Solution for injection 50 mg/ml 5 ml in ampoules No.5

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions

Marketing Authorization No. UA/15072/01/01

LASOLEKS

Solution for inhalation and oral use 2 ml No. 5

1 ml of the drug contains ambroxol hydrochloride 7.5 mg;

Mucolytic agent.

Marketing Authorization No. UA/12750/02/01

RHEUMASTOP

Solution for injection 10 mg/ml 1.5 ml in ampoules No.5

Rheumastop is a non-steroid anti-inflammatory drug (NSAID) of enolic acid class, which has anti-inflammatory, analgesic and anti-pyretic effect

Marketing Authorization No. UA/12990/01/01

EMETON 2 ml No.5

Solution for injection 2 mg/ml 2 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3

Marketing Authorization No. UA/13447/01/01

BUPIVACAINE

Solution for injection 5 mg/ml 10 ml in ampoules No.10

1 ml of the solution contains 5 mg of bupivacaine hydrochloride

Drug of choice being used for epidural, conduction and infiltration anesthesia if a significant long-lasting effect is needed

Marketing Authorization No. UA/13416/01/01

BUPIVACAINE SPINAL

Solution for injection 5 mg/ml 4 ml in ampoules No.5

1 ml of the solution contains 5 mg of bupivacaine hydrochloride

Highly-effective product for spinal anesthesia

Marketing Authorization No. UA/13417/01/01

PHARMAXON 4 ml No.5

Solution for injection 250 mg/ml 4 ml in ampoules No.5

1 ml of the solution contains 250 mg of citicoline

Psychostimulant and nootropic product

Marketing  Authorization No. UA/13932/01/01

NIKOMEX 2 ml No.10

Solution for injection 50 mg/ml 2 ml in ampoules No.10

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions

Marketing Authorization No. UA/15072/01/01

LASOLEKS

Solution for injection 7.5 mg/ml 2 ml in ampoules No.5

Mucolytic product

It increases lung secretion, increases lung surfactant release and also stimulates ciliary epithelium activity, which results in better mucus release and its excretion and eases  cough

Marketing Authorization No. UA/12750/01/01

TIVARGIN-N

Solution for infusions, 100 ml in vials No. 1 in a cardboard pack

1 ml contains 42 mg of arginine hydrochloride (100 ml contains 20 mmol of arginine and 20 mmol of chlorides)

Blood substitutes and perfusion solutions

Marketing Authorization UA/19033/01/01

MIOLOCARD  5 ml No.10

Solution for injection 100 mg/ml 5 ml in ampoules No.10

1 ml of the solution contains 100 mg of 3-(2,2,2- trimethylhydrazinium) propionate dehydrate (meldonium)

Antihypoxic and cytoprotective product which increases cell load tolerance

Marketing Authorization No. UA/15151/01/01

SULFOCAINE

Solution for injections of 2 ml No. 10

1 ml of mixture: DL-sulfocamphoric acid 49.6 mg, novocaine base 50.4 mg;

Marketing Authorization No. UA/20409/01/01

DIСLASEL

solution for injection 2 ml No. 10

1 ml contains: diclofenac sodium 37.5 mg and

lidocaine hydrochloride 10 mg;

Non-steroidal anti-inflammatory and anti-rheumatic drugs.

Marketing Authorization No. UA/20506/01/01

LICARTIN-N 200

Solution for injection 200 mg/ml, 5 ml No. 5

1 ml of solution contains 200 mg or 400 mg of levocarnitine;

Amino acids and their derivatives. Levocarnitine.

Marketing Authorization No. UA/20488/01/01

LICARTIN-N 400

Solution for injection 400 mg/ml, 5 ml No. 5

1 ml of solution contains 200 mg or 400 mg of levocarnitine;

Amino acids and their derivatives. Levocarnitine.

Marketing Authorization No. UA/20488/01/02

VAZITREN

Solution for injection 20 mg/ml 5 ml in ampoules No.5

The product belongs to the group of peripheral vasodilators

It  blocks aggregation of thrombocytes and erythrocytes, increases their flexibility, reduces the high fibrinogen concentration in blood plasma and increases fibrinolysis which in its turn reduces blood viscosity and improves its rheological properties

Marketing Authorization No. UA/14521/01/01

LEVOCIN-N

Solution for infusion 100 ml of the solution contains 500 mg of levofloxacin.100 and 150 ml in the bottle; 1 bottle per folding box.

The product demonstraters a wide anti-bacterial effect.

Marketing Authorization No. UA/12842/01/01

GEPATOX

Concentrate for solution for infusion 10 ml in ampoules No.10

1 ml of the concentrate contains 500 mg of L-ornithine-L-aspartate

Marketing Authorization UA/12890/01/01

AVECIN-N

1 vial (250 mL) contains moxifloxacin 400 mg, equivalent to 436 mg of moxifloxacin hydrochloride;

Antimicrobial agents for systemic use. Antibacterial agents of the quinolone group.

Marketing Authorization No. UA/20053/01/01

EMETON 4 ml No.5

Solution for injection 2 mg/ml 4 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3

Marketing Authorization No. UA/13447/01/01

TORACETAM

Solution for injection 200 mg/ml 5 ml in ampoules No.10

Other psychostimulants and nootropics

Improves the efficiency of cognitive functions

Marketing Authorization No. UA/20267/01/01

NOPAIN-N

Solution for injections of 10 mg/ml of 1 ml in ampoules No.10

and 2 ml each in ampoules No.5

Analgesics. Opioids. Morphinan derivatives.

Powerful analgesic

Marketing Authorization No. UA/20278/01/01

TRIAZOFAM 25

Solution for injections of 25 mg/ml in 2 ml ampoules No. 10 and 4 ml No. 10

Cardiac drugs. Other cardiac drugs. Thiazotic acid.

Marketing Authorization No. UA/20268/01/01

TRIAZOFAM 50

Solution for injections of 50 mg/ml in 2 ml ampoules No. 10 and 4 ml No. 10

Cardiac drugs. Other cardiac drugs. Thiazotic acid.

Marketing Authorization No. UA/20280/01/01

ANTYHISTYN

Solution for injections 20 mg/ml, 5 ampoules of 1 ml

Antihistamines for systemic use.

The drug relieves the general symptoms of allergic diseases, in addition to anti-allergic, has a sedative, soporific and antipruritic effect.

Marketing Authorization No. UA/20272/01/01